XORTX Therapeutics Inc. submitted a 6-K filing reporting their obligations under the Securities Exchange Act as of January 6, 2025. This is a standard filing indicating compliance with regulatory requirements.
AI Assistant
XORTX THERAPEUTICS INC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.